Prostate Cancer Clinical Trials in Ohio

Showing 301-320 of 345 trials

COMPLETEDNA32 miles

Prostate Biomarkers in Men Consuming Tomato Products

NCT02292524

Prostate Biomarkers in Men Consuming Tomato Products

Prostate Cancer

Ohio State University Comprehensive Cancer Center33 participantsStarted May 2002

Columbus, Ohio, United States

COMPLETEDPhase 278 miles

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

NCT00087139

Drugs used in chemotherapy, such as ixabepilone, work in different ways to stop tumor cells from dividing so they stop growing or die. This phase II trial is studying how well ixabepilone works in treating patients with metastatic prostate cancer that has not responded to previous hormone therapy.

Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer

National Cancer Institute (NCI)124 participantsStarted Sep 2004

Aurora, Colorado, United States • Boulder, Colorado, United States • Colorado Springs, Colorado, United States +159 more locations

Prostate Biomarkers in Men Consuming Tomato Products

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

Prostate Cancer Trials in Other Cities

A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer

Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration

A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer

A Trial of Degarelix in Patients With Prostate Cancer

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants

Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer

Safety and Efficacy of Kanglaite Gelcaps in Prostate Cancer

Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer

Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer

Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer

Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy

Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer

Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel

Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer

Other Conditions in Ohio